(Q73794617)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

K T Kivistö

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T S Lamberg

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T Kantola

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P J Neuvonen

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

348-354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Metabolism and disposition of buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

In vitro metabolism of the antianxiety drug buspirone as a predictor of its metabolism in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Lack of interaction between cimetidine and buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

A study of pharmacokinetic interaction between buspirone and alprazolam at steady state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

A potentially hazardous interaction between erythromycin and midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Simultaneous high-performance liquid chromatographic analysis of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in plasma using electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Determination of erythromycin base and 2'-acetylerythromycin in human plasma using high-performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Determination of itraconazole in serum with high-performance liquid chromatography and fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Rifampin drastically reduces plasma concentrations and effects of oral midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

First-pass metabolism of midazolam by the human intestine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990038-2

10.1016/S0009-9236(97)90038-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9333111%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference